PTG Capital
Next-gen Buyout Firm Focused on Acquiring and Scaling MNC Divestitures into Cross-regional Platforms
Who we are
PTG Capital is a next-generation PE firm specializing in acquiring and growing MNC divestitures in pharma and medtech across Asia-Pacific region, leveraging proprietary deal sourcing, deep domain expertise, activist operator-investor approach and visible exit strategy to unlock hidden value and drive scalable growth
An Alterative Route to Build Market-leading Business while derisking capital deployment
– Founded by seasoned executives with hands-on deal execution, business development and operational experiences, completing 25+ complex transactions totaling $2B+ EV
– Headquartered in Singapore & Hong Kong, with a broad global BD networkcovering US, Europe, China, Japan, and APAC
– Focused on proprietary sourcing and bilateral negotiations to acquire compelling MNC divestitures in select therapeutic areas
– Deep-rooted sector expertise enables uncovering hidden complexities, unarticulated value drivers, and integration risks beyond seller materials
– Possessing extensive know-how in achieving standalone operations and post-close optimization across tech transfer, manufacturing, supply chain, and commercialization
– Partner closely with select incumbent executives to source, transform and grow carve-outs into cross-regional champions, bolstered by add-on acquisitions and licensing deals
– Engaging strategic buyers and capital markets early on —or syndicating with them—to generate demand for future exits
Proactive and Proprietary Sourcing
Early and Direct engagement with sellers to secure early, off-market MNC divestitures; Lead or syndicate deals with strategic buyers/PE firms where auctions are unavoidable.
Maximizing Standalone Readiness
Deep dive on target and collaboration with seller to ensure maximizedoperationaland organizational independence to derisk future standaloneand avoid pitfall.
Value Creation Activism
Ops plan clearly devised during deal process, identifying at least 5 critical value levers;
Drive ops improvements and accelerate growth with a hands-on activist approach.
Platform Scaling
Leveraging our deep-rooted BD expertise to build on initial acquisition and expand via bolt-on M&A and licensing to deepen market presence andbroadenproduct portfolio.
Exit Strategy
Engaging strategic buyers and capital markets early on to generate demand for exits;
Tailored IPO or strategic trade sales aligned with regional and global market conditions.